We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.9B
AUM Growth
+$82.9M
Cap. Flow
-$1.22B
Cap. Flow %
-8.19%
Top 10 Hldgs %
17.88%
Holding
1,150
New
131
Increased
316
Reduced
491
Closed
190

Top Buys

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$108M
2
T icon
AT&T
T
+$102M
3
VLO icon
Valero Energy
VLO
+$70.6M
4
MPC icon
Marathon Petroleum
MPC
+$53.5M
5
BMY icon
Bristol-Myers Squibb
BMY
+$51.5M

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Healthcare 14.02%
3 Consumer Discretionary 12.92%
4 Financials 11.35%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELTX icon
951
Elicio Therapeutics
ELTX
$77.5M
$131K ﹤0.01%
+4,524
New +$229K
STTK icon
952
Shattuck Labs
STTK
$651M
$128K ﹤0.01%
+15,059
New +$207K
RUBY
953
DELISTED
Rubius Therapeutics, Inc
RUBY
$124K ﹤0.01%
12,771
-13,210
-51% -$183K
CORR
954
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$116K ﹤0.01%
36,971
MNTX
955
DELISTED
Manitex International, Inc.
MNTX
$91K ﹤0.01%
14,300
-3,200
-18% -$21K
INFI
956
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$53K ﹤0.01%
23,557
-54,228
-70% -$136K
SYBX
957
DELISTED
Synlogic
SYBX
$46K ﹤0.01%
1,265
-5,134
-80% -$199K
HIL
958
DELISTED
Hill International, Inc. Common Stock
HIL
$39K ﹤0.01%
20,166
-209,140
-91% -$431K
CARM
959
DELISTED
Carisma Therapeutics
CARM
$9K ﹤0.01%
+577
New +$11.6K
AAP icon
960
Advance Auto Parts
AAP
$3.54B
-5,861
Closed -$1.22M
ACN icon
961
Accenture
ACN
$101B
-15,407
Closed -$4.93M
ADP icon
962
Automatic Data Processing
ADP
$106B
-1,024
Closed -$205K
AFG icon
963
American Financial Group
AFG
$12B
-13,037
Closed -$1.64M
ALOT icon
964
AstroNova
ALOT
$224M
-24,507
Closed -$369K
ALTG icon
965
Alta Equipment Group
ALTG
$207M
-10,143
Closed -$139K
AMT icon
966
American Tower
AMT
$79.9B
-12,112
Closed -$3.21M
APRE icon
967
Aprea Therapeutics
APRE
$7.6M
-2,660
Closed -$272K
ASAN icon
968
Asana
ASAN
$1.89B
-3,500
Closed -$363K
ASMB icon
969
Assembly Biosciences
ASMB
$507M
-16,713
Closed -$698K
ASUR icon
970
Asure Software
ASUR
$237M
-14,057
Closed -$127K
OPTU
971
Optimum Communications Inc
OPTU
$298M
-928,737
Closed -$19.2M
AVNT icon
972
Avient
AVNT
$3.41B
-26,320
Closed -$1.22M
BDX icon
973
Becton Dickinson
BDX
$45.8B
-1,538
Closed -$369K
BELFB
974
Bel Fuse Inc Class B
BELFB
$3.57B
-128,393
Closed -$1.6M
BLKB icon
975
Blackbaud
BLKB
$1.65B
-10,420
Closed -$733K

Similar funds

Jacobs Levy Equity Management's Q4 2021 Portfolio in Review

As of Q4 2021, Jacobs Levy Equity Management held 1,150 positions worth $14.9B, up 0.56% from $14.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Jacobs Levy Equity Management withdrew a net $1.22B in Q4 2021, closing 190 positions and reducing 491 holdings. Its most notable exit was Cerner Corp, an estimated $46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Jacobs Levy Equity Management opened a new position in Booking.com worth $109M.

  • Jacobs Levy Equity Management's largest Q4 2021 buy was Booking.com: 1,135,900 shares worth $109M.
  • Jacobs Levy Equity Management added most to AT&T in Q4 2021, an estimated $102M increase.
  • Jacobs Levy Equity Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $89.1M.
  • Jacobs Levy Equity Management fully exited Cerner Corp in Q4 2021, selling an estimated $46M.
  • Jacobs Levy Equity Management's ten largest holdings make up 18% of its $14.9B portfolio in Q4 2021.
  • Jacobs Levy Equity Management opened 131 new positions and closed 190 in Q4 2021.
  • Jacobs Levy Equity Management's portfolio value rose 0.56% quarter-over-quarter to $14.9B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.